Browse drugs

…ngle-arm trials. Fourteen studies evaluated biologic therapies: infliximab (n=5), adalimumab (n=2), etanercept (n=2), golimumab (n=1), rit…

…nt was treated with a combination of immunotherapies, including methylprednisolone, rituximab and intravenous immunoglobulin, with partial clinica…

… Randomised controlled trial evidence now supports early use of rituximab (within 1 year of generalised disease onset), although the evid…

… immune thrombocytopenic purpura. A 32-year-old woman was given eltrombopag (a thrombopoietin receptor agonist) to treat presumed immune th…

…quently gave intravenous rituximab and C5a receptor antagonist, avacopan. He recovered well and remains in remission.…

…vels and low C5 activity, confirming transplacental transfer of ravulizumab. The infant, now 4 months old, remains well.Conclusions This is…

…eline American College of Rheumatology classification criteria, rituximab use at baseline and highest completed level of parent/guardian …

…er an rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone treatment.This case illustrates that cPTLD should be included i…

…patients with autoimmune rheumatic diseases (AIRD) treated with rituximab (RTX).Methods Single-centre, retrospective cohort study of pati…